Learn 3 Ways to Optimize Your Companion Diagnostic Strategy

Companion Diagnostics Expertise

The development of biomarkers and companion diagnostics is an integral component in drug development programs, especially for personalized medicines. You need one global partner with a deep understanding of clinical development, diagnostic development, regulatory requirements and strategic partnership models to ensure you achieve better outcomes.

Download our new CDx infographic to learn how our most trusted scientific experts can help you:

  • Simplify and align co-development strategies
  • Accelerate your time to market
  • Increase the probability of regulatory and commercial success
Contact us today to learn how we can put our experience and expertise to work for you by ensuring success in your next companion diagnostic development program.

Contact Q2 Solutions
Talk To an Expert Contact Our Offices

More Resources

Learn 3 Ways Anatomic Pathology Drives Advancements in Immuno-Oncology
6 Key Elements of Successful Companion Diagnostic Development
Fighting Cancer: How Biomarker Testing and 3 Key Research Tools Shape Immunotherapy Drug Development
View All